CURX (Curanex Pharmaceuticals Inc Common Stock) Stock Analysis - Hedge Fund Holdings

Curanex Pharmaceuticals Inc Common Stock (CURX) is a publicly traded the market company. As of May 21, 2026, CURX trades at $0.33 with a market cap of $8.53M and a P/E ratio of -1.91. CURX moved +0.00% today. Year to date, CURX is -9.92%; over the trailing twelve months it is flat. Its 52-week range spans $0.26 to $9.18. Rallies surfaces CURX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns CURX stock?

Rallies tracks hedge fund and 13F ownership for CURX, including fund holders, share counts, and position changes when data is available.

CURX Key Metrics

Key financial metrics for CURX
MetricValue
Price$0.33
Market Cap$8.53M
P/E Ratio-1.91
EPS$-0.17
Dividend Yield0.00%
52-Week High$9.18
52-Week Low$0.26
Volume120.50K
Avg Volume0
Revenue (TTM)$0
Net Income$-4.23M
Gross Margin0.00%

Latest CURX News

CURX Analyst Consensus

CURX analyst coverage data. Average price target: $0.00.

Common questions about CURX

Who owns CURX stock?
Rallies tracks hedge fund and 13F ownership for CURX, including fund holders, share counts, and position changes when data is available.
Does Rallies show 13F holders for CURX?
Yes. Rallies tracks hedge fund and 13F ownership data for CURX, including fund names, share counts, latest tracked quarter, and position changes when available.
Is CURX research on Rallies investment advice?
No. Rallies provides research, data, and educational context for CURX. It does not provide personalized investment advice.
CURX

CURX